Literature DB >> 20388741

Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis.

Nicola Alcorn, Ann Tierney, Olivia Wu, Harper Gilmour, Rajan Madhok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20388741     DOI： 10.1136/ard.2009.122424

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis.

Authors:  Rachel A Brown; Domenico Spina; Sayqa Butt; Gregory D Summers
Journal:  Clin Rheumatol       Date:  2011-10-19       Impact factor: 2.980

2.  Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.

Authors:  Diana S Novikova; Helen V Udachkina; Eugenia I Markelova; Irina G Kirillova; Anna S Misiyuk; Natalia V Demidova; Tatiana V Popkova
Journal:  Rheumatol Int       Date:  2019-05-03       Impact factor: 2.631

3.  Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.

Authors:  Paolo Sfriso; Francesco Caso; Giuseppe Sebastiano Filardo; Costantino Botsios; Luisa Costa; Raffaele Scarpa; Silvano Todesco; Paolo Spinella; Francesca Oliviero; Leonardo Punzi
Journal:  Clin Rheumatol       Date:  2016-04-06       Impact factor: 2.980

4.  Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis.

Authors:  Anne Tournadre; Bruno Pereira; Fréderic Dutheil; Charlotte Giraud; Daniel Courteix; Vincent Sapin; Thomas Frayssac; Sylvain Mathieu; Sandrine Malochet-Guinamand; Martin Soubrier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-03-18       Impact factor: 12.910

5.  Weight Gain and Hair Loss during Anti-TNF Therapy.

Authors:  Abdo Lutf; Mohammed Hammoudeh
Journal:  Int J Rheumatol       Date:  2012-08-05

6.  The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis.

Authors:  Magdalena Pirowska; Aleksander Obtułowicz; Sylwia Lipko-Godlewska; Anna Goździalska; Katarzyna Podolec; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.